Get the Stockscreener App
13.99
2.17%
-0.31
After Hours:
13.97
-0.02
-0.14%
Overview
News
Price History
Option Chain
Why RDY Down?
Discussions
Forecast
Stock Split
Dividend History
Dr Reddys Laboratories Ltd Adr Stock (RDY) Forecast
The Dr Reddys Laboratories Ltd Adr (RDY) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $75.09, representing a +436.72% increase from the current price of $13.99. The highest analyst price target is $77.15, and the lowest is $73.03.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RDY Price Target
Average 91.31
(+552.69% Upside)
Is Dr Reddys Laboratories Ltd Adr (RDY) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 31.36 | Neutral |
| STOCH(9,6) | 14.44 | Buy |
| STOCHRSI(14) | 11.18 | Buy |
| MACD(12,26) | -0.373 | Sell |
| ADX(14) | 34.78 | Sell |
| William %R | -95.61 | Buy |
| CCI(14) | -101.64 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
14.46
Sell
|
14.40
Sell
|
| MA20 |
14.74
Sell
|
14.71
Sell
|
| MA50 |
15.38
Sell
|
15.19
Sell
|
| MA100 |
15.78
Sell
|
15.34
Sell
|
| MA200 |
15.19
Sell
|
15.06
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RDY could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 13 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on RDY, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 31.36 indicates that RDY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.44 indicates that RDY is oversold. This indicates that RDY price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.18 indicates that RDY is oversold. This suggests that RDY price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.78 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -101.64 indicates that RDY is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term RDY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Dr Reddys Laboratories Ltd Adr financial reports and earnings history, Dr Reddys Laboratories Ltd Adr (RDY) stock could reach $106.71 by 2030, $217.69 by 2040 and $287.46 by 2050. See the projected annual prices until 2050 of the Dr Reddys Laboratories Ltd Adr stock below:
- Dr Reddys Laboratories Ltd Adr (RDY) is expected to reach an average price of $178.71 in 2035, with a high prediction of $179.54 and a low estimate of $173.69. This indicates an $1,177% rise from the last recorded price of $13.99.
- Dr Reddys Laboratories Ltd Adr (RDY) stock is projected to chart a bullish course in 2040, with an average price target of $217.43, representing an $1,454% surge from its current level. The forecast ranges from a conservative $213.00 to a sky-high $217.69.
- Our analysts predict Dr Reddys Laboratories Ltd Adr (RDY) to jump 1,690% by 2045, soaring from $247.24 to an average price of $250.36, potentially reaching $252.29. While $247.24 is the low estimate, the potential upside is significant.
- Dr Reddys Laboratories Ltd Adr (RDY) stock is expected to climb by 2050, reaching an average of $286.82, a $1,950% jump from its current level. However, a wide range of estimates exists, with high and low targets of $287.46 and $280.73, respectively, highlighting the market's uncertainty.
Dr Reddys Laboratories Ltd Adr Stock (RDY) Year by Year Forecast
Dr Reddys Laboratories Ltd Adr Stock (RDY) Price Forecast for 2024
Our forecast for RDY stock price in 2024 now indicates an average price target of $72.44 with a high forecast of $77.72 and a low forecast of $67.16. The average prediction reflects an increase of +417.80% from the last recorded price of $13.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $75.63 | $73.03 | $77.15 | +440.63% |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Price Forecast for 2025
Dr Reddys Laboratories Ltd Adr Stock (RDY) is expected to reach an average price of $91.31 in 2025, with a high prediction of $112.68 and a low estimate of $69.94. This indicates an +552.69% rise from the last recorded price of $13.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $75.92 | $75.27 | $76.72 | +442.64% |
| February, 2025 | $79.72 | $75.57 | $80.69 | +469.81% |
| March, 2025 | $76.32 | $76.26 | $82.33 | +445.53% |
| April, 2025 | $77.31 | $69.94 | $79.53 | +452.61% |
| May, 2025 | $87.64 | $75.78 | $89.60 | +526.48% |
| June, 2025 | $87.13 | $86.72 | $91.02 | +522.78% |
| July, 2025 | $91.04 | $86.12 | $92.67 | +550.72% |
| August, 2025 | $90.25 | $89.36 | $93.17 | +545.10% |
| September, 2025 | $99.36 | $89.57 | $100.53 | +610.24% |
| October, 2025 | $97.81 | $96.47 | $101.27 | +599.16% |
| November, 2025 | $108.92 | $97.26 | $112.68 | +678.53% |
| December, 2025 | $104.60 | $104.17 | $110.91 | +647.64% |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Price Forecast for 2026
The predicted value for Dr Reddys Laboratories Ltd Adr (RDY) in 2026 is set at an average of $108.84. Estimates vary from a peak of $118.55 to a trough of $99.13, indicating an +677.97% surge from the present price of $13.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $105.50 | $102.46 | $108.41 | +654.10% |
| February, 2026 | $111.01 | $105.27 | $111.25 | +693.51% |
| March, 2026 | $111.88 | $108.33 | $114.14 | +699.68% |
| April, 2026 | $104.49 | $99.44 | $111.27 | +646.93% |
| May, 2026 | $100.60 | $99.13 | $104.02 | +619.07% |
| June, 2026 | $105.85 | $100.78 | $105.92 | +656.63% |
| July, 2026 | $114.36 | $104.51 | $115.36 | +717.45% |
| August, 2026 | $116.76 | $113.86 | $116.81 | +734.63% |
| September, 2026 | $117.09 | $113.48 | $118.55 | +736.98% |
| October, 2026 | $107.89 | $105.82 | $117.87 | +671.18% |
| November, 2026 | $108.03 | $103.84 | $108.34 | +672.20% |
| December, 2026 | $109.41 | $108.50 | $111.84 | +682.06% |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Dr Reddys Laboratories Ltd Adr (RDY) is $103.14, with a high forecast of $111.82 and a low forecast of $94.45. This indicates an +637.21% increase from the last price of $13.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $105.97 | $105.23 | $111.82 | +657.50% |
| February, 2027 | $107.28 | $105.10 | $110.44 | +666.82% |
| March, 2027 | $105.82 | $104.31 | $108.25 | +656.38% |
| April, 2027 | $108.35 | $105.73 | $111.40 | +674.48% |
| May, 2027 | $103.81 | $100.03 | $109.02 | +642.06% |
| June, 2027 | $95.64 | $94.89 | $104.52 | +583.65% |
| July, 2027 | $102.56 | $94.45 | $103.81 | +633.07% |
| August, 2027 | $101.07 | $101.00 | $105.28 | +622.45% |
| September, 2027 | $103.91 | $97.02 | $104.27 | +642.74% |
| October, 2027 | $101.15 | $100.40 | $104.36 | +623.04% |
| November, 2027 | $103.93 | $102.45 | $104.51 | +642.86% |
| December, 2027 | $102.36 | $99.54 | $105.95 | +631.64% |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Price Forecast for 2028
In 2028, Dr Reddys Laboratories Ltd Adr (RDY) is projected to reach an average price of $107.85, with a high projection of $116.50 and a low estimate of $99.20. This indicates an +670.91% rise from the last price of $13.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $101.02 | $100.60 | $102.82 | +622.08% |
| February, 2028 | $101.74 | $99.20 | $103.41 | +627.25% |
| March, 2028 | $104.14 | $100.03 | $105.04 | +644.41% |
| April, 2028 | $104.84 | $103.63 | $107.65 | +649.36% |
| May, 2028 | $103.19 | $102.73 | $107.00 | +637.56% |
| June, 2028 | $104.60 | $101.80 | $105.34 | +647.67% |
| July, 2028 | $106.20 | $102.20 | $106.56 | +659.13% |
| August, 2028 | $105.15 | $103.79 | $106.96 | +651.62% |
| September, 2028 | $110.86 | $104.82 | $110.92 | +692.46% |
| October, 2028 | $113.19 | $110.75 | $113.81 | +709.07% |
| November, 2028 | $109.56 | $105.70 | $113.24 | +683.12% |
| December, 2028 | $116.29 | $108.96 | $116.50 | +731.25% |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Price Forecast for 2029
The 2029 price forecast for Dr Reddys Laboratories Ltd Adr Stock (RDY) is $120.10 on average, with a high prediction of $134.25 and a low estimate of $105.94. This represents an +758.44% increase from the previous price of $13.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $122.29 | $114.95 | $122.53 | +774.13% |
| February, 2029 | $124.25 | $122.10 | $127.12 | +788.16% |
| March, 2029 | $124.15 | $121.03 | $124.59 | +787.40% |
| April, 2029 | $121.07 | $119.74 | $123.53 | +765.41% |
| May, 2029 | $120.52 | $118.70 | $122.85 | +761.48% |
| June, 2029 | $124.99 | $120.02 | $125.36 | +793.45% |
| July, 2029 | $125.34 | $120.09 | $125.75 | +795.91% |
| August, 2029 | $128.14 | $123.18 | $129.79 | +815.92% |
| September, 2029 | $134.12 | $127.63 | $134.25 | +858.69% |
| October, 2029 | $130.44 | $129.02 | $134.21 | +832.38% |
| November, 2029 | $128.44 | $128.02 | $131.57 | +818.11% |
| December, 2029 | $106.38 | $105.94 | $132.70 | +660.40% |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Price Forecast for 2030
Dr Reddys Laboratories Ltd Adr Stock (RDY) is expected to reach an average price of $110.12 in 2030, with a high forecast of $118.54 and a low forecast of $101.71. This signifies an +687.15% surge from the last price of $13.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $102.75 | $101.71 | $106.71 | +634.46% |
| February, 2030 | $104.33 | $101.82 | $105.25 | +645.72% |
| March, 2030 | $102.94 | $102.80 | $105.88 | +635.79% |
| April, 2030 | $103.28 | $102.09 | $103.96 | +638.24% |
| May, 2030 | $106.53 | $102.84 | $108.28 | +661.46% |
| June, 2030 | $108.52 | $105.53 | $109.25 | +675.66% |
| July, 2030 | $109.94 | $108.00 | $110.79 | +685.88% |
| August, 2030 | $111.60 | $110.33 | $112.30 | +697.72% |
| September, 2030 | $112.49 | $111.26 | $113.27 | +704.06% |
| October, 2030 | $117.79 | $111.98 | $118.51 | +741.94% |
| November, 2030 | $111.84 | $109.43 | $118.54 | +699.46% |
| December, 2030 | $114.55 | $106.55 | $115.16 | +718.81% |
1.01%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):